LOWER GORNAL MEDICAL PRACTICE — All Prescriptions & Medications — Page 3
Practice Code: M87015 | DUDLEY, DY3 2NQ
Showing results 101-150 of 607
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| 391 | 47.1K | £1.7K | +41.4% ▲ | |
| Zopiclone | 389 | 7,725 | £345 | -29.8% ▼ |
| Digoxin | 384 | 15.4K | £1.1K | +1.5% vs avg |
| Fluticasone propionate/azelastine hydrochloride (Nasal) | 383 | 398 | £5.6K | +237.7% ▲ |
| Codeine phosphate | 379 | 30.2K | £1.1K | -47.3% ▼ |
| Estradiol with progestogen | 375 | 19.2K | £10.5K | +10.0% ▲ |
| Betahistine hydrochloride | 372 | 31.8K | £1.0K | +55.8% ▲ |
| Sacubitril/valsartan | 358 | 23.2K | £37.9K | +49.5% ▲ |
| Spironolactone | 355 | 12.9K | £1.1K | -34.2% ▼ |
| Combined ethinylestradiol 30mcg | 355 | 28.6K | £1.7K | +27.8% ▲ |
| Carbomer 940/980 | 333 | 4,770 | £987 | +118.7% ▲ |
| Insulin aspart | 332 | 1,834 | £11.0K | -12.8% ▼ |
| Mirabegron | 328 | 12.6K | £11.6K | -18.3% ▼ |
| Glyceryl trinitrate | 322 | 421 | £800 | +36.1% ▲ |
| 314 | 49.8K | £4.0K | +209.1% ▲ | |
| Tirzepatide | 312 | 316 | £30.2K | +60.6% ▲ |
| Mebeverine hydrochloride | 311 | 31.6K | £1.2K | +0.2% vs avg |
| Meloxicam | 307 | 10.4K | £336 | +364.1% ▲ |
| Lacidipine | 297 | 14.8K | £1.2K | +148.5% ▲ |
| Lactulose | 286 | 129.4K | £1.2K | -13.1% ▼ |
| BeclometDiprop/Formoterol/Glycopyrronium (Corticosteroids) | 279 | 304 | £13.5K | +66.8% ▲ |
| Methotrexate | 279 | 6,026 | £2.2K | -14.3% ▼ |
| 279 | 2,820 | £1.5K | +11.8% ▲ | |
| Linagliptin | 272 | 13.2K | £14.9K | -33.6% ▼ |
| 272 | 138.3K | £2.0K | +3.1% ▲ | |
| 265 | 7,621 | £2.8K | +242.7% ▲ | |
| Cetirizine hydrochloride | 264 | 20.1K | £899 | -47.2% ▼ |
| Phenoxymethylpenicillin (Penicillin V) | 254 | 28.9K | £1.1K | -17.1% ▼ |
| Warfarin sodium | 250 | 23.2K | £762 | -47.0% ▼ |
| Lercanidipine hydrochloride | 245 | 12.8K | £1.3K | -60.3% ▼ |
| 245 | 257 | £1.4K | +3.7% ▲ | |
| Trimethoprim | 243 | 12.4K | £608 | +18.9% ▲ |
| 239 | 2,605 | £838 | +14.4% ▲ | |
| 233 | 33.0K | £1.1K | -50.9% ▼ | |
| Sodium valproate | 228 | 70.1K | £5.5K | -28.3% ▼ |
| Paroxetine hydrochloride | 226 | 11.3K | £433 | +21.1% ▲ |
| Progesterone | 226 | 16.3K | £3.3K | -46.0% ▼ |
| Lidocaine hydrochloride | 222 | 4,192 | £1.8K | +28.7% ▲ |
| Famotidine | 221 | 12.1K | £6.9K | -54.7% ▼ |
| Risperidone | 220 | 9,776 | £447 | -13.0% ▼ |
| Biphasic insulin aspart | 220 | 1,805 | £10.8K | +116.7% ▲ |
| Hyoscine butylbromide | 218 | 22.0K | £1.5K | -6.5% ▼ |
| Docusate sodium | 216 | 21.1K | £1.5K | -41.7% ▼ |
| Eplerenone | 216 | 7,686 | £937 | -18.5% ▼ |
| Beclometasone dipropionate | 215 | 231 | £649 | +0.0% vs avg |
| Senna | 210 | 11.5K | £296 | -65.1% ▼ |
| Dexamethasone | 207 | 1,205 | £751 | +20.4% ▲ |
| Alogliptin | 204 | 9,548 | £8.6K | -19.6% ▼ |
| Sumatriptan succinate | 201 | 2,030 | £3.8K | -43.2% ▼ |
| Mesalazine (Systemic) | 199 | 18.8K | £11.1K | -16.9% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.